Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining Overall Improvement in the Quality of Life of Individuals Receiving Human Umbilical Cord Blood Plasma

NCT03229785 is registered in ClinicalTrials.gov with Hexagon Therapies, LLC as lead sponsor.

NCT NCT03229785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03229785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining Overall Improvement in the Quality of Life of Individuals Receiving Human Umbilical Cord Blood Plasma
Lead sponsor
Hexagon Therapies, LLC
Phase
Phase 1
Overall status
Unknown status
Start date
April 1, 2018
Completion date
August 1, 2019
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aging